CDRH To Consider Future Priorities In New “Stabilized” User Fee Climate
This article was originally published in The Gray Sheet
Executive Summary
CDRH senior staff will meet in late August to iron out fiscal year 2006 priorities now that they have a clearer picture of expected user fee revenues
You may also be interested in...
CDRH Unveils Postmarket Safety “Action Items”
FDA's plan to strengthen postmarket device safety by making better use of postmarket data includes modifying its organizational infrastructure, updating adverse event reporting practices and potentially increasing the use of fines for certain types of industry noncompliance
CDRH Unveils Postmarket Safety “Action Items”
FDA's plan to strengthen postmarket device safety by making better use of postmarket data includes modifying its organizational infrastructure, updating adverse event reporting practices and potentially increasing the use of fines for certain types of industry noncompliance
Device Center Director Schultz Floats User Fees For Postmarket Efforts
FDA is considering proposing that device user fees help fund postmarket as well as premarket activities, according to CDRH Director Dan Schultz